Lenz Therapeutics, Inc. — Form D

Lenz Therapeutics, Inc. of DEL MAR, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-14. The offering totals $250K, of which $250K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
Mark W LesterExecutive OfficerWellesley, MA
Zach ScheinerDirectorBoston, MA
CHRIS DIMITROPOULOSDirectorSAN DIEGO, CA
Clare OzawaDirectorSouth San Francisco, CA
Evert SchimmelpenninkDirectorBryan, TX
Evert SchimmelpenninkExecutive OfficerBryan, TX
Mark LesterExecutive OfficerTucson, AZ
James McCollumDirectorDel Mar, CA
James McCollumExecutive OfficerDel Mar, CA
Stefan LarsonDirectorDel Mar, CA
Frederic GuerardDirectorDedham, MA
Fred GuerardDirectorDel Mar, CA
Mark W LesterDirectorWellesley, MA
Gerald W HornDirectorDeerfield, IL
Gerald W HornExecutive OfficerDeerfield, IL
James W McCollumDirectorCoronado, CA
James W McCollumExecutive OfficerCoronado, CA
GERALD HORNExecutive OfficerCORONADO, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-03-10D$83.5M$83.5M
2022-11-22D/A$49.0M$49.0M
2020-11-09D$68.3M$1.8M
2016-06-30D$3.4M$3.4M

More